Michael Gould to Risk Assessment
This is a "connection" page, showing publications Michael Gould has written about Risk Assessment.
Connection Strength
1.843
-
Identifying patients with symptoms suspicious for COVID-19 at elevated risk of adverse events: The COVAS score. Am J Emerg Med. 2021 Aug; 46:489-494.
Score: 0.540
-
Associations between physical activity and 30-day readmission risk in chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2014 Jun; 11(5):695-705.
Score: 0.346
-
Multilevel Barriers to the Successful Implementation of Lung Cancer Screening: Why Does It Have to Be So Hard? Ann Am Thorac Soc. 2017 Aug; 14(8):1261-1265.
Score: 0.108
-
Factors Associated with a Positive Baseline Screening Exam Result in the National Lung Screening Trial. Ann Am Thorac Soc. 2016 09; 13(9):1568-74.
Score: 0.101
-
Functional status at discharge and 30-day readmission risk in COPD. Respir Med. 2015 Feb; 109(2):238-46.
Score: 0.090
-
Evaluation of individuals with pulmonary nodules: when is it lung cancer? Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013 May; 143(5 Suppl):e93S-e120S.
Score: 0.080
-
When the average applies to no one: personalized decision making about potential benefits of lung cancer screening. Ann Intern Med. 2012 Oct 16; 157(8):571-3.
Score: 0.077
-
Decision making in patients with pulmonary nodules. Am J Respir Crit Care Med. 2012 Feb 15; 185(4):363-72.
Score: 0.072
-
Effectiveness and cost effectiveness of thrombolysis in patients with acute pulmonary embolism. Curr Opin Pulm Med. 2008 Sep; 14(5):422-6.
Score: 0.058
-
A clinical prediction rule to estimate the probability of mediastinal metastasis in patients with non-small cell lung cancer. J Thorac Oncol. 2006 Nov; 1(9):953-9.
Score: 0.051
-
Risk models for VTE and bleeding in medical inpatients: systematic identification and expert assessment. Blood Adv. 2020 06 23; 4(12):2557-2566.
Score: 0.033
-
Management of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic: CHEST Expert Panel Report. Chest. 2020 07; 158(1):406-415.
Score: 0.033
-
Clinical Equipoise and Shared Decision-making in Pulmonary Nodule Management. A Survey of American Thoracic Society Clinicians. Ann Am Thorac Soc. 2017 Jun; 14(6):968-975.
Score: 0.027
-
Procedure-specific Risks of Thrombosis and Bleeding in Urological Cancer Surgery: Systematic Review and Meta-analysis. Eur Urol. 2018 02; 73(2):242-251.
Score: 0.026
-
Procedure-specific Risks of Thrombosis and Bleeding in Urological Non-cancer Surgery: Systematic Review and Meta-analysis. Eur Urol. 2018 02; 73(2):236-241.
Score: 0.026
-
Physician Assessment of Pretest Probability of Malignancy and Adherence With Guidelines for Pulmonary Nodule Evaluation. Chest. 2017 08; 152(2):263-270.
Score: 0.026
-
Management of Pulmonary Nodules by Community Pulmonologists: A Multicenter Observational Study. Chest. 2015 Dec; 148(6):1405-1414.
Score: 0.024
-
Components necessary for high-quality lung cancer screening: American College of Chest Physicians and American Thoracic Society Policy Statement. Chest. 2015 Feb; 147(2):295-303.
Score: 0.023
-
Lung cancer screening. Am J Respir Crit Care Med. 2015 Jan 01; 191(1):19-33.
Score: 0.023
-
What do you mean, a spot?: A qualitative analysis of patients' reactions to discussions with their physicians about pulmonary nodules. Chest. 2013 Mar; 143(3):672-677.
Score: 0.020
-
Approach to outcome measurement in the prevention of thrombosis in surgical and medical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012 Feb; 141(2 Suppl):e185S-e194S.
Score: 0.018
-
Catheter-directed therapy for the treatment of massive pulmonary embolism: systematic review and meta-analysis of modern techniques. J Vasc Interv Radiol. 2009 Nov; 20(11):1431-40.
Score: 0.016
-
An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations. Am J Respir Crit Care Med. 2006 Sep 01; 174(5):605-14.
Score: 0.013
-
Impact of genetic counseling on primary and preventive care in obstetrics and gynecology. J Reprod Med. 1999 Jan; 44(1):7-10.
Score: 0.007
-
The usefulness of a prenatal genetic questionnaire in genetic risk assessment. Obstet Gynecol. 1996 Nov; 88(5):806-10.
Score: 0.006